Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | XDH | P47989 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8430723 | 0.82 | RXRA (0.43) | MAPTPPARGABCG2MAOBMEN1 | |
| SCHEMBL8428198 | 0.81 | PPARG (0.50) | MAPTPPARGRELAMAOBXDH | |
| SCHEMBL8428249 | 0.77 | MEN1 (0.35) | ARMAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL8432124 | 0.76 | MAOB (0.45) | MAPTMAPK1L3MBTL1PPARGMAOB | |
| SCHEMBL8428246 | 0.75 | RXRA (0.48) | MAPTMAPK1TDP1PPARGMEN1 | |
| SCHEMBL8432058 | 0.72 | PPARG (0.40) | MAPTMAPK1TDP1PPARGEGFR | |
| SCHEMBL8155195 | 0.69 | PPARG (0.52) | MAPTPPARGMAOBMEN1KMT2A | |
| SCHEMBL8155194 | 0.69 | PPARG (0.52) | MAPTPPARGMAOBMEN1KMT2A | |
| SCHEMBL8154646 | 0.68 | RXRA (0.44) | MAPTPPARGABCG2MAOBMEN1 | |
| SCHEMBL8154649 | 0.68 | RXRA (0.44) | MAPTPPARGABCG2MAOBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965619-A | ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION | CELL PATHWAYS INC. (US) | 1999-10-12 | — | — | US | disclosed |